Cancer immunoconjugates: will clinical success lead to commercial success?
B J
BJ
Spalding
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D001709:Biotechnology / Q000191:economics*; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D009369:Neoplasms / Q000628:therapy*; D011868:Radioisotopes / Q000627:therapeutic use; D012276:Ricin / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000922:Immunotoxins; D011868:Radioisotopes; D012276:Ricin